While both urologists and PCPs were highly aware of US Preventive Services Task Force guidelines, PCPs were much less likely than urologists to believe in the value of PSA testing or the role of early detection to prevent prostate cancer–related mortality (2 [6.5%] vs 24 [75.0%], respectively). This evidence concerns the gene KLK3 and Familial prostate cancer.